Literature DB >> 26154424

A Case of Dominant Dystrophic Epidermolysis Bullosa Responding Well to an Old Medication.

Jordan Leung1, Paul Kuzel1, Anil Kurian1, Alain Brassard1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26154424     DOI： 10.1001/jamadermatol.2015.1791

Source DB:  PubMed          Journal:  JAMA Dermatol        ISSN： 2168-6068            Impact factor:   10.282


× No keyword cloud information.
  2 in total

Review 1.  Novel and emerging therapies in the treatment of recessive dystrophic epidermolysis bullosa.

Authors:  Ellie Rashidghamat; John A McGrath
Journal:  Intractable Rare Dis Res       Date:  2017-02

Review 2.  Small molecule drug development for rare genodermatoses - evaluation of the current status in epidermolysis bullosa.

Authors:  Verena Wally; Manuela Reisenberger; Sophie Kitzmüller; Martin Laimer
Journal:  Orphanet J Rare Dis       Date:  2020-10-19       Impact factor: 4.123
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.